Previous Article | Next Article 
Molecular and Cellular Biology, May 2003, p. 3646-3655, Vol. 23, No. 10
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.10.3646-3655.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Modeling del(17)(p11.2p11.2) and dup(17)(p11.2p11.2) Contiguous Gene Syndromes by Chromosome Engineering in Mice: Phenotypic Consequences of Gene Dosage Imbalance
Katherina Walz,1 Sandra Caratini-Rivera,1 Weimin Bi,1 Patricia Fonseca,1 Dena L. Mansouri,1 Jennifer Lynch,2 Hannes Vogel,3 Jeffrey L. Noebels,2 Allan Bradley,4 and James R. Lupski1,5,6*
Departments of Molecular and Human Genetics,1
Pediatrics,5
Neurology (Neurosensory Center), Baylor College of Medicine,2
Texas Children's Hospital, Houston, Texas,6
Department of Pathology (Neuropathology), Stanford University Medical Center, Stanford, California,3
Sanger Centre, Cambridge, United Kingdom4
Received 3 January 2003/
Returned for modification 11 February 2003/
Accepted 27 February 2003
Contiguous gene syndromes (CGS) are a group of disorders associated with chromosomal rearrangements of which the phenotype is thought to result from altered copy numbers of physically linked dosage-sensitive genes. Smith-Magenis syndrome (SMS) is a CGS associated with a deletion within band p11.2 of chromosome 17. Recently, patients harboring the predicted reciprocal duplication product [dup(17)(p11.2p11.2)] have been described as having a relatively mild phenotype. By chromosomal engineering, we created rearranged chromosomes carrying the deletion [Df(11)17] or duplication [Dp(11)17] of the syntenic region on mouse chromosome 11 that spans the genomic interval commonly deleted in SMS patients. Df(11)17/+ mice exhibit craniofacial abnormalities, seizures, marked obesity, and male-specific reduced fertility. Dp(11)17/+ animals are underweight and do not have seizures, craniofacial abnormalities, or reduced fertility. Examination of Df(11)17/Dp(11)17 animals suggests that most of the observed phenotypes result from gene dosage effects. Our murine models represent a powerful tool to analyze the consequences of gene dosage imbalance in this genomic interval and to investigate the molecular genetic bases of both SMS and dup(17)(p11.2p11.2).
* Corresponding author. Mailing address: Dept. of Molecular and Human Genetics, Baylor College of Medicine, Room 604B, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-6530. Fax: (713) 798-5073. E-mail: jlupski{at}bcm.tmc.edu.
Molecular and Cellular Biology, May 2003, p. 3646-3655, Vol. 23, No. 10
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.10.3646-3655.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Molina, J., Carmona-Mora, P., Chrast, J., Krall, P. M., Canales, C. P., Lupski, J. R., Reymond, A., Walz, K.
(2008). Abnormal social behaviors and altered gene expression rates in a mouse model for Potocki-Lupski syndrome. Hum Mol Genet
17: 2486-2495
[Abstract]
[Full Text]
-
Bi, W., Yan, J., Shi, X., Yuva-Paylor, L. A., Antalffy, B. A., Goldman, A., Yoo, J. W., Noebels, J. L., Armstrong, D. L., Paylor, R., Lupski, J. R.
(2007). Rai1 deficiency in mice causes learning impairment and motor dysfunction, whereas Rai1 heterozygous mice display minimal behavioral phenotypes. Hum Mol Genet
16: 1802-1813
[Abstract]
[Full Text]
-
Li, Z., Yu, T., Morishima, M., Pao, A., LaDuca, J., Conroy, J., Nowak, N., Matsui, S.-I., Shiraishi, I., Yu, Y. E.
(2007). Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet
16: 1359-1366
[Abstract]
[Full Text]
-
Yu, Y. E., Morishima, M., Pao, A., Wang, D.-Y., Wen, X.-Y., Baldini, A., Bradley, A.
(2006). A Deficiency in the Region Homologous to Human 17q21.33-q23.2 Causes Heart Defects in Mice. Genetics
173: 297-307
[Abstract]
[Full Text]
-
Goldman, A. M., Potocki, L., Walz, K., Lynch, J. K., Glaze, D. G., Lupski, J. R., Noebels, J. L.
(2006). Topical Review: Epilepsy and Chromosomal Rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)]. J Child Neurol
21: 93-98
[Abstract]
-
Bi, W., Ohyama, T., Nakamura, H., Yan, J., Visvanathan, J., Justice, M. J., Lupski, J. R.
(2005). Inactivation of Rai1 in mice recapitulates phenotypes observed in chromosome engineered mouse models for Smith-Magenis syndrome. Hum Mol Genet
14: 983-995
[Abstract]
[Full Text]
-
Yan, J., Keener, V. W., Bi, W., Walz, K., Bradley, A., Justice, M. J., Lupski, J. R.
(2004). Reduced penetrance of craniofacial anomalies as a function of deletion size and genetic background in a chromosome engineered partial mouse model for Smith-Magenis syndrome. Hum Mol Genet
13: 2613-2624
[Abstract]
[Full Text]
-
Walz, K., Spencer, C., Kaasik, K., Lee, C. C., Lupski, J. R., Paylor, R.
(2004). Behavioral characterization of mouse models for Smith-Magenis syndrome and dup(17)(p11.2p11.2). Hum Mol Genet
13: 367-378
[Abstract]
[Full Text]
Copyright © 2003 by the American Society for Microbiology. All rights reserved.